A chromatin immunoprecipitation assay further confirmed the enrichment of β-catenin on the TCF/LEF consensus sites of CCR2 promoter in CRC cells and human CRC tissues (Fig. 5d). This evidence concerns the gene CCR2 and colorectal carcinoma.